Cargando…

An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.

We have characterised an etoposide-resistant subline of the small-cell lung cancer cell line, UMCC-1, derived at our centre. Subline UMCC-1/VP was developed by culturing the parent line in increasing concentrations of etoposide over 16 months. UMCC-1/VP is 20-fold resistant to etoposide by MTT assay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doyle, L. A., Ross, D. D., Ordonez, J. V., Yang, W., Gao, Y., Tong, Y., Belani, C. P., Gutheil, J. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033885/ https://www.ncbi.nlm.nih.gov/pubmed/7669558

Ejemplares similares

Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline
por: Felipe, Aledson Vitor, et al.
Publicado: (2018)

Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
por: Song, Wen-ping, et al.
Publicado: (2020)

The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines
por: Kostrzewa-Nowak, D, et al.
Publicado: (2005)

Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.
por: O'Neill, G. M., et al.
Publicado: (1998)

Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
por: Stephens, T. C., et al.
Publicado: (1986)

Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
por: Versantvoort, C. H., et al.
Publicado: (1995)

Development of Mouse Ascites Tumour Sublines Resistant to Triethylene Melamine
por: Williams, Anna Maria, et al.
Publicado: (1961)

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.
por: Philip, P. A., et al.
Publicado: (1992)

Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.
por: Schneider, E., et al.
Publicado: (1995)

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis
por: Smonskey, Matthew, et al.
Publicado: (2016)

FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide
por: Ma, Jian, et al.
Publicado: (2017)

Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.
por: Souès, S., et al.
Publicado: (1995)

Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012)

Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines
por: Chen, Ming, et al.
Publicado: (2015)

Draft Genome Sequence of the Multiple Antibiotic Resistant Pseudomonas aeruginosa PAO1-UB Subline
por: Chua, Kah-Ooi, et al.
Publicado: (2022)

Tumour Incidence and Tumour-Free Sublines in BR6 Mice
por: Mundy, J., et al.
Publicado: (1961)

Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)

Overexpression of sorcin in multidrug-resistant human breast cancer
por: GONG, ZHAOHUA, et al.
Publicado: (2014)

Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
por: Cowie, F. J., et al.
Publicado: (1995)

Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
por: Souissi, Wided, et al.
Publicado: (2022)

Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines
por: ARAKAWA, YASUHIRO, et al.
Publicado: (2013)

Genomic Adaption and Mutational Patterns in a HaCaT Subline Resistant to Alkylating Agents and Ionizing Radiation
por: Ullmann, Reinhard, et al.
Publicado: (2021)

Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline
por: Boichuk, Sergei, et al.
Publicado: (2023)

Intracellular Levels of Two Cyclosporin Derivatives Valspodar (PSC 833) and Cyclosporin A Closely Associated with Multidrug Resistance‐modulating Activity in Sublines of Human Colorectal Adenocarcinoma HCT‐15
por: Uchiyama‐Kokubu, Noriko, et al.
Publicado: (2001)

Transactions on rough sets IV: journal subline
por: Hutchison, David, et al.
Publicado: (2005)

Identity of tumorigenic human urothelial cell lines and 'spontaneously' transformed sublines.
por: Christensen, B., et al.
Publicado: (1993)

Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line
por: Xie, Si Ming, et al.
Publicado: (2010)

Overexpression of Multidrug Resistance Protein Gene in Human Cancer Cell Lines Selected for Drug Resistance to Epipodophyllotoxins
por: Koike, Koji, et al.
Publicado: (1996)

Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline
por: Yates, C, et al.
Publicado: (2005)

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
por: Capolongo, L., et al.
Publicado: (1993)

Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
por: Izquierdo, M. A., et al.
Publicado: (1996)

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
por: Qiu, Zhengang, et al.
Publicado: (2019)

Pericentromeric Satellite III transcripts induce etoposide resistance
por: Kanne, Julian, et al.
Publicado: (2021)

Molecular determinants of etoposide resistance in HL60 cells
por: Alghamdi, Rasha H, et al.
Publicado: (2022)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)

Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants
por: Pavillard, V, et al.
Publicado: (2001)

The behaviour in rats of tumour sublines of low and high malignancy.
por: Williams, A. E., et al.
Publicado: (1968)

Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by (1)H NMR spectroscopy
por: Dewar, Brian J., et al.
Publicado: (2010)

Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.
por: Ota, E., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_cbj7q74ot6k5r5nag6mieu07uc